We are live on
!
Find out more
E
Ergoteles Portfolio holdings
AUM
$68.2M
1-Year Est. Return
36.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.32%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.72B
AUM Growth
-$123M
(-4.3%)
Cap. Flow
-$215M
Cap. Flow
% of AUM
-7.9%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
2,200
New
704
Increased
294
Reduced
353
Closed
800
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$85.8M |
| 2 |
Steel Dynamics
STLD
|
+$50.2M |
| 3 |
McKesson
MCK
|
+$43.7M |
| 4 |
STOR
STORE Capital Corporation
STOR
|
+$38.2M |
| 5 |
Arch Capital
ACGL
|
+$26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$149M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$147M |
| 3 |
NLSN
Nielsen Holdings plc
NLSN
|
+$44.3M |
| 4 |
CoStar Group
CSGP
|
+$44.2M |
| 5 |
Chevron
CVX
|
+$43.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.28% |
| 2 | Healthcare | 12.35% |
| 3 | Industrials | 12.24% |
| 4 | Technology | 10.34% |
| 5 | Consumer Discretionary | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
TransUnion
TRU
$14.8B
| $1.03M | 0.04% |
18,175
+13,494
| +288% | +$791K |
|
452
First Bancorp
FBP
$4.4B
| $1.03M | 0.04% |
80,652
-11,281
| -12% | -$165K |
|
453
Carpenter Technology
CRS
$30B
| $1.02M | 0.04% |
+27,530
| New | +$1.05M |
|
454
PACCAR
PCAR
$69.6B
| $1.01M | 0.04% |
+15,275
| New | +$998K |
|
455
Enphase Energy
ENPH
$4.84B
| $1.01M | 0.04% |
3,794
-2,368
| -38% | -$689K |
|
456
Onto Innovation
ONTO
$13.6B
| $1M | 0.04% |
+14,736
| New | +$1.06M |
|
|
VXRT
457
DELISTED
Vaxart
VXRT
| $1,000K | 0.04% |
+1,040,648
| New | +$1.47M |
|
|
AZEK
458
DELISTED
The AZEK Co
AZEK
| $997K | 0.04% |
49,074
-62,022
| -56% | -$1.15M |
|
459
Owens Corning
OC
$11.5B
| $994K | 0.04% |
+11,655
| New | +$1.02M |
|
460
Brookfield Renewable
BEPC
$6.12B
| $990K | 0.04% |
35,931
+27,178
| +310% | +$839K |
|
461
Factset
FDS
$9.05B
| $989K | 0.04% |
+2,466
| New | +$1.05M |
|
|
KYNB
462
Kyntra Bio
KYNB
$28.5M
| $988K | 0.04% |
2,466
-1,592
| -39% | -$610K |
|
|
SYNH
463
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $987K | 0.04% |
26,922
-22,605
| -46% | -$894K |
|
464
WillScot Mobile Mini Holdings
WSC
$4.8B
| $987K | 0.04% |
+21,840
| New | +$980K |
|
465
News Corp Class B
NWS
$16.4B
| $985K | 0.04% |
+53,400
| New | +$941K |
|
|
MLVF
466
DELISTED
Malvern Bancorp, Inc.
MLVF
| $983K | 0.04% |
+55,370
| New | +$840K |
|
467
Liberty Broadband Class C
LBRDK
$4.15B
| $982K | 0.04% |
12,876
+9,924
| +336% | +$807K |
|
|
RVNC
468
DELISTED
Revance Therapeutics, Inc.
RVNC
| $980K | 0.04% |
53,078
+26,369
| +99% | +$603K |
|
469
Wabtec
WAB
$51.1B
| $977K | 0.04% |
+9,793
| New | +$936K |
|
470
Comfort Systems
FIX
$61B
| $967K | 0.04% |
+8,403
| New | +$977K |
|
471
CNX Resources
CNX
$4.85B
| $963K | 0.04% |
+57,200
| New | +$987K |
|
472
American Vanguard Corp
AVD
$73.5M
| $962K | 0.04% |
+44,296
| New | +$987K |
|
473
Haemonetics
HAE
$3.58B
| $958K | 0.04% |
12,180
+2,153
| +21% | +$173K |
|
474
Vivid Seats
SEAT
$77M
| $952K | 0.04% |
+6,520
| New | +$1.01M |
|
475
West Pharmaceutical
WST
$23.1B
| $948K | 0.03% |
4,030
-3,039
| -43% | -$720K |
|
Similar funds
ROC
IVMX
AM
JCG
JAMONY
FA
VCM
MCMI
Ergoteles's Q4 2022 Portfolio in Review
As of Q4 2022, Ergoteles held 2,200 positions worth $2.72B, down 4.3% from $2.85B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Ergoteles withdrew a net $215M in Q4 2022, closing 800 positions and reducing 353 holdings. Its most notable exit was Citrix Systems Inc, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ergoteles opened a new position in McKesson worth $43.9M.
- Ergoteles's largest Q4 2022 buy was McKesson: 117,079 shares worth $43.9M.
- Ergoteles added most to iShares Biotechnology ETF in Q4 2022, an estimated $85.8M increase.
- Ergoteles's biggest Q4 2022 reduction was Alphabet (Google) Class C, cutting an estimated $41.8M.
- Ergoteles fully exited Citrix Systems Inc in Q4 2022, selling an estimated $149M.
- Ergoteles's ten largest holdings make up 17% of its $2.72B portfolio in Q4 2022.
- Ergoteles opened 704 new positions and closed 800 in Q4 2022.
- Ergoteles's portfolio value fell 4.3% quarter-over-quarter to $2.72B.
Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.